These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 334333)

  • 21. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphographic studies in malabsorption syndromes in the adult].
    Rimondi C; Lupi GL
    Haematologica; 1970; 55(10):666-7. PubMed ID: 4996537
    [No Abstract]   [Full Text] [Related]  

  • 24. Stevens Johnson syndrome/toxic epidermal necrolysis after exogenous contact to S,S-dimethyl cyanoimidodithiocarbonate.
    Schedel F; Herrnstadt G; Ehrchen J
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e96-e97. PubMed ID: 27401191
    [No Abstract]   [Full Text] [Related]  

  • 25. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-1985. A 55-year-old man with diarrhea, dilatation of the small bowel, and hepatosplenomegaly.
    N Engl J Med; 1985 Apr; 312(14):905-14. PubMed ID: 3871911
    [No Abstract]   [Full Text] [Related]  

  • 26. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired ichthyosis revealing an Hodgkin's disease].
    Ennibi K; Rabhi M; Al Bouzidi A; Bahrouch L; Boudlal M; Zinebi A; Akhouad Y; Berady S; Chaari J; Toloune F
    Rev Med Interne; 2008 May; 29(5):418-20. PubMed ID: 18221824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome?
    Murata J; Abe R
    J Invest Dermatol; 2007 Apr; 127(4):744-5. PubMed ID: 17363955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case Report of Toxic Epidermal Necrolysis Due to Ofloxacin.
    Vaghela JJ; Nimbark VN; Chavda BC; Mehta HH; Purohit BM
    Curr Drug Saf; 2018; 13(2):137-140. PubMed ID: 29506464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Togo: the role of self-medication].
    Saka B; Kombaté K; Egbohou P; Mouhari-Toure A; Akakpo S; Boukari T; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):486-7. PubMed ID: 22721483
    [No Abstract]   [Full Text] [Related]  

  • 34. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Williams PM; Conklin RJ
    Dent Clin North Am; 2005 Jan; 49(1):67-76, viii. PubMed ID: 15567361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the blood protein disorder in malabsorption syndromes of intestinal origin].
    Bozzetti E; Bolandrina E
    Arch Sci Med (Torino); 1966 Oct; 122(4):249-61. PubMed ID: 5340419
    [No Abstract]   [Full Text] [Related]  

  • 37. An autopsy case of malignant lymphoma with Lyell's syndrome.
    Sadi AM; Toda T; Kiyuna M; Tamamoto T; Ohshiro K; Shinzato R
    J Dermatol; 1995 Aug; 22(8):594-9. PubMed ID: 7560459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics.
    Chaby G; Ingen-Housz-Oro S; De Prost N; Wolkenstein P; Chosidow O; Fardet L
    J Am Acad Dermatol; 2019 May; 80(5):1453-1455. PubMed ID: 30395917
    [No Abstract]   [Full Text] [Related]  

  • 39. [Associated tuberculosis and reticulosarcoma of mesenteric lymph nodes].
    Shlimovich BA; Kas'ianova NV; Galiev ShS; Babaev RIu
    Probl Tuberk; 1977 Oct; (10):82-3. PubMed ID: 337291
    [No Abstract]   [Full Text] [Related]  

  • 40. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.